Genesco Inc (GCO) 51.90 $GCO After Yesterday's Rally of

New Post Public Reply Private Reply Replies (0) Message Board

Sep 22, 2016 at 7:00 AM

Genesco Inc (GCO) 51.90 $GCO

After Yesterday's Rally of 2.58% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Sep 12, 3:09PM CDT
Genesco (NYSE:GCO) traded in a range yesterday that spanned from a low of $48.44 to a high of $50.06. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $49.47 on volume of 109,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GCO: 51.90 (+0.40)

What Falling Estimates & Price Mean for Genesco (GCO)
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 7:44AM CDT
Genesco (GCO) has witnessed a significant price decline in the past four weeks, and it has lately seen negative earnings estimate revisions as well.
PLCE: 80.15 (-2.64), GCO: 51.90 (+0.40)

Post Earnings Coverage as Genesco Sales Decline 4 Percent
ACCESSWIRE - Thu Sep 08, 8:01AM CDT
LONDON, UK / ACCESSWIRE / September 8, 2016 / Active Wall St. announces its post-earnings coverage on Genesco Inc. (NYSE: GCO). The company released its second quarter fiscal 2017 results on September 01st, 2016. The apparel maker reported a drop in revenue in its second quarter results and gave a disappointing full-year outlook. Register with us now for your free membership at: http://www.activewallst.com/register/.
GCO: 51.90 (+0.40)

New Strong Sell Stocks for September 7th
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 10:11AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
ACET: 19.25 (+0.30), WBMD: 49.04 (+0.14), FOGO: 11.33 (-0.14), GCO: 51.90 (+0.40), DG: 72.18 (+0.46)

Genesco (GCO) Hits 52-Week Low: Why is it Losing Sheen?
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 7:26AM CDT
Genesco (GCO) has been losing sheen as shares of this Zacks Rank #4 (Sell) company continue to decline.
TLYS: 9.71 (+0.20), URBN: 35.76 (+0.14), PLCE: 80.15 (-2.64), GCO: 51.90 (+0.40)

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation against Genesco Inc. and Advises Investors with Losses to Contact the Firm
BusinessWire - Fri Sep 02, 10:54AM CDT
Goldberg Law PC announces that it is investigating Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO) concerning possible violations of federal securities laws.
GCO: 51.90 (+0.40)

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Genesco Inc. Investors
BusinessWire - Fri Sep 02, 9:30AM CDT
Glancy Prongay & Murray LLP ("GPM"

announces an investigation on behalf of Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO) investors concerning the Company and its officers' possible violations of federal securities laws.
GCO: 51.90 (+0.40)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Genesco Inc. (GCO)
PR Newswire - Fri Sep 02, 9:25AM CDT
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO). Such investors are advised to contact Peretz Bronstein or his investor relations analyst, Yael Hurwitz at info@bgandg.com or 212-697-6484.
GCO: 51.90 (+0.40)

Genesco (GCO) Tops Q2 Earnings, Misses Sales, Trims View
Zacks Equity Research - Zacks Investment Research - Fri Sep 02, 7:38AM CDT
Genesco (GCO) shares plunged nearly 32.8% after it posted mixed second-quarter fiscal 2017 numbers.
TLYS: 9.71 (+0.20), URBN: 35.76 (+0.14), PLCE: 80.15 (-2.64), GCO: 51.90 (+0.40)

GENESCO (GCO) ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Initiates Investigation of Genesco Inc.; Encourages Any Investor Who Suffered Losses to Contact the Firm
PR Newswire - Fri Sep 02, 6:14AM CDT
Johnson & Weaver, LLP has commenced an investigation concerning whether Genesco Inc. (NYSE: GCO) violated federal securities laws. Genesco retails and wholesales footwear, apparel, and accessories.
GCO: 51.90 (+0.40)

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Genesco Inc.
BusinessWire - Thu Sep 01, 5:48PM CDT
Khang & Khang LLP (the "Firm"

announces that it is investigating claims against Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO) concerning possible violations of federal securities laws.
GCO: 51.90 (+0.40)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws by Certain Officers and Directors of Genesco Inc.
BusinessWire - Thu Sep 01, 4:55PM CDT
Levi & Korsinsky announces it has commenced an investigation of Genesco Inc. (NYSE:GCO) ("Genesco"

concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors.
GCO: 51.90 (+0.40)

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Genesco Inc. and Advises Investors With Losses to Contact the Firm
BusinessWire - Thu Sep 01, 4:00PM CDT
Lundin Law PC (http://lundinlawpc.com/) announces it is investigating claims against Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO) concerning possible violations of federal securities laws.
GCO: 51.90 (+0.40)

INVESTOR ALERT: Investigation of Genesco Inc. Announced by Law Offices of Howard G. Smith
BusinessWire - Thu Sep 01, 2:29PM CDT
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO) concerning the Company and its officers' possible violations of federal securities laws.
GCO: 51.90 (+0.40)

INVESTOR ALERT: Goldberg Law PC Announces an Investigation against Genesco Inc. and Advises Investors with Losses to Contact the Firm
BusinessWire - Thu Sep 01, 1:39PM CDT
Goldberg Law PC announces that it is investigating Genesco Inc. ("Genesco" or the "Company"

(NYSE: GCO) concerning possible violations of federal securities laws.
GCO: 51.90 (+0.40)

Genesco Falls 30.75% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Sep 01, 12:26PM CDT
Genesco (NYSE:GCO) traded in a range yesterday that spanned from a low of $49.60 to a high of $57.98. Yesterday, the shares fell 30.8%, which took the trading range below the 3-day low of $71.83 on volume of 2.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
GCO: 51.90 (+0.40)

SHAREHOLDER ALERT: Investigation of Genesco Announced by Holzer & Holzer
BusinessWire - Thu Sep 01, 11:12AM CDT
Holzer & Holzer, LLC is investigating whether certain statements made by Genesco, Inc. ("Genesco" or the "Company"

(NYSE: GCO) regarding its business and operations complied with federal securities laws. On September 1, 2016, Genesco announced its second quarter results and lowered its earnings forecast. The price of Genesco's stock declined following the announcement.
GCO: 51.90 (+0.40)

Genesco Reports Second Quarter Fiscal 2017 Results
PR Newswire - Thu Sep 01, 5:47AM CDT
Genesco Inc. (NYSE: GCO) today reported earnings from continuing operations for the second quarter ended July 30, 2016, of $14.5 million, or $0.72 per diluted share, compared to earnings from continuing operations of $7.6 million, or $0.32 per diluted share, for the second quarter ended August 1, 2015. Fiscal 2017 second quarter results reflect a pretax gain of $10.4 million, or $0.38 per diluted share after tax, including an $8.9 million gain on network intrusion expenses as a result of a litigation settlement and a $2.5 million gain on the sale of Lids Team Sports, partially offset by $1.0 million for asset impairment charges. Fiscal 2016 second quarter results reflect pretax items of $1.8 million, or $0.04 per share after tax, including $0.6 million of expenses related to deferred purchase price payments in connection with the acquisition of Schuh Group Limited, which was required to be expensed as compensation because the payment was contingent upon the payees' continued employment; and $1.2 million for asset impairment charges and network intrusion expenses.
GCO: 51.90 (+0.40)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie Knepp Joins Exceptional Women Alliance

A New Chapter for a Seasoned Leader When a high flyer like Stephanie Knepp steps into a new arena, you know folks are going to sit up and pay attention. This time, she's making waves by joining the Exceptional Women Alliance (EWA), a heavy-hitting community of women leaders. With her extensive background in scaling businesses and empowering leaders, she's bound to bring...

Qfin Holdings Faces Securities Fraud Class Action Challenges

Troubles Mount for Qfin Holdings Well, you don't need a crystal ball to see this storm brewing for Qfin Holdings, Inc. (NASDAQ:QFIN). On the heels of a nasty 18.91% nosedive in their stock price, a class action lawsuit is looming overhead like a mischievous cloud ready to rain on investors' parades. It's the kind of legal and financial brew that could leave shareholders...

Direct Connection Unleashes Powerful HEMI V8 Engine Programs

HEMI V8 Legacy Reinvention at SEMA 2026 If you're the sort who gets their hands greasy restoring or revamping classic muscle, well, Direct Connection just made your life a whole lot easier. Stellantis' performance arm pulled the wraps off not just one, but six new HEMI V8 crate engine packages at the 2026 SEMA Show. Now, that's how you turn heads in Vegas. A New...

Lumentum Holders Question Marvell Deal Fairness: Legal Eyes

What's Brewing with Lumentum and Marvell? There's no denying the chatter on Wall Street when there's a potential shake-up, especially with a big merger at stake. We're staring down the barrel of an investigation concerning Lumentum Holdings Inc. (NASDAQ: LITE) and Marvell Technology, Inc.'s deal. The M&A Class Action Firm, helmed by Juan Monteverde, is the name leading...

PrimeBOT: Breaking Tech Molds with Celeb Backing

Not Your Average Tech Buzz It starts with Hollywood glitz and an unexpected dance partner. The PrimeBOT, a Chinese personal robot, is ditching the drab tech corner and seeping into mainstream culture. Imagine Johnny Depp slapping some paint on this machine alongside local kids. Now, picture the Kardashians casually dining with it, letting it join their lunchtime...

Synova Global Taps Eventus for Top Trade Surveillance

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Moberg Pharma Secures U.S. Patent for MOB-015 Innovation

Moberg Pharma's Fresh U.S. Patent: A Game Changer? Moberg Pharma just snagged a U.S. patent for their whiz-bang dosing of MOB-015. Yup, the FDA’s go-ahead is still out of reach, but this patent is like hitting a full house on the river—sweetening the pot significantly. It's all about onychomycosis, or nail fungus, if you're not up on your medical terms. With patent...

NJ Small Businesses: Free IT Security Checks Offered

Unpacking Corporate Technologies' Offer It's not every day a company doles out free consultations, but Corporate Technologies is doing just that. They're tossing New Jersey's small-to-mid businesses a lifeline with free IT and cybersecurity assessments. There's no catch, just thirty minutes of pure, no-nonsense evaluation of your tech setup. Couldn’t hurt to know where...

Wincomm & Portwell Unveil Medical AI Tech at MEDICA 2026

MEDICA 2026: Wincomm and Portwell Join Forces November's got one heck of an event lined up with MEDICA 2026, where Wincomm and Portwell are teaming up to showcase what they've got up their sleeves in medical AI computing. This whole shebang runs from November 16 to 19, with their setup in Hall 12, Stand C76, Düsseldorf, Germany. But why should investors care? Because...

Differentia Bio's AI: Transforming Drug Development Dynamics

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...